Try our beta test site
2 studies found for:    21844910 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention:
2 Recruiting Characterization of Rebound Pain Following Peripheral Nerve Block and Its Association With Gut Microbiome Diversity
Conditions: Pain, Postoperative;   Gastrointestinal Microbiome
Intervention:

Study has passed its completion date and status has not been verified in more than two years.